The effects of concomitant immunomodulators on the pharmacokinetics, efficacy and safety of adalimumab in paediatric patients with Crohn’s disease: a post hoc analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The effects of concomitant immunomodulators on the pharmacokinetics, efficacy and safety of adalimumab in paediatric patients with Crohn’s disease: a post hoc analysis

Published:2018-12-02 Issue:2 Volume:49 Page:155-164
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Hyams Jeffrey S.¹^ORCID,Dubinsky Marla²,Rosh Joel³,Ruemmele Frank M.⁴,Eichner Samantha F.⁵,Maa Jen-Fue⁵,Lazar Andreas⁶,Alperovich Gabriela⁷,Mostafa Nael M.⁵,Robinson Anne M.⁵

Affiliation:

1. Connecticut Children’s Medical Center; Hartford Connecticut

2. Icahn School of Medicine at Mount Sinai; New York City New York

3. Goryeb Children’s Hospital/Atlantic Health; Morristown New Jersey

4. Universite Sorbonne Paris-Cite, Hospital Necker-Enfants Malades; Paris France

5. AbbVie Inc.; North Chicago Illinois

6. AbbVie Deutschland GmbH & Co. KG; Ludwigshafen Germany

7. AbbVie Inc.; Madrid Spain

Funder

AbbVie

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.15054/fullpdf

Reference34 articles.

1. Risk of malignancies in patients with inflammatory bowel disease treated with thiopurines or anti-TNF alpha antibodies;Beigel;Pharmacoepidemiol Drug Saf,2014

2. Increased risk of malignancy with adalimumab combination therapy, compared with monotherapy, for Crohn's disease;Osterman;Gastroenterology,2014

3. Effectiveness and safety of immunomodulators with anti-tumor necrosis factor therapy in Crohn's disease;Osterman;Clin Gastroenterol Hepatol,2015

4. A systematic review of factors that contribute to hepatosplenic T-cell lymphoma in patients with inflammatory bowel disease;Kotlyar;Clin Gastroenterol Hepatol,2011

5. Infliximab, azathioprine, or combination therapy for Crohn's disease;Colombel;N Engl J Med,2010

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Endoscopic Healing and Durability between Combination Therapy with Infliximab and Azathioprine versus Infliximab Monotherapy in Pediatric Crohn's disease;2024-06-25

2. Medical management of pediatric inflammatory bowel disease;Seminars in Pediatric Surgery;2024-04

3. Durability of Adalimumab and Infliximab in Children With Crohn’s Disease: A Nationwide Comparison From the epi-IIRN Cohort;Inflammatory Bowel Diseases;2024-01-08

4. Infliximab vs adalimumab: Points to consider when selecting anti-tumor necrosis factor agents in pediatric patients with Crohn’s disease;World Journal of Gastroenterology;2023-05-14

5. Therapeutic Drug Monitoring in Pediatric Inflammatory Bowel Disease;Pediatric Inflammatory Bowel Disease;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3